No Data
No Data
Express News | Abbott: Advisor™ Hd Grid X Mapping Catheter, Sensor Enabled™, Receives U.S. Food & Drug Administration Clearance, Begins Commercial Launch
Express News | Abbott: Global Focalflex Trial Now Underway for Abbott's Tactiflex™ Duo Ablation Catheter, Sensor Enabled™
Abbott Advances Pulsed Field Ablation Clinical Studies and Launches New Technology to Support Advanced Cardiac Mapping
Express News | Abbott : JP Morgan Raises Target Price to $135 From $125
Investors Heavily Search Abbott Laboratories (ABT): Here Is What You Need to Know
RBC Capital raised abbott laboratories' target price to $130.
October 9th RBC Capital: Abbott Laboratories' target price has been raised from $125 to $130, maintaining an "outperform" rating.